onkoserv

aktuelle literatur

31.10.2012

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

Indikationen:
Ovarialkarzinom, Peritonealkarzinom, primäres, Tubenkarzinom
Substanzen:
Celecoxib

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials

Indikationen:
Mammakarzinom
Substanzen:
5-Fluorouracil, Methotrexat, Cyclophosphamid, Epirubicin

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phase III trial

Indikationen:
CML
Substanzen:
Imatinib
30.10.2012

Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide

Indikationen:
Mammakarzinom
Substanzen:
Docetaxel

Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma

Indikationen:
Hodgkin-Lymphom
Substanzen:
Radiotherapie

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

Indikationen:
Prostatakarzinom
Substanzen:
Docetaxel, Abirateron
29.10.2012

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma

Indikationen:
Pankreaskarzinom
Substanzen:
Gemcitabin, Radiotherapie, Cetuximab

Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer

Indikationen:
Mammakarzinom
Substanzen:
Zytostatika generell

ARIX: A randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer

Indikationen:
Kopf- und Hals- Tumore
Substanzen:
Radiotherapie, Akupunktur
26.10.2012

Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma

Indikationen:
Hodgkin-Lymphom, Stammzellmobilisierung, Stammzelltransplantation